The Global European: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Global European.

Press releases published on November 9, 2026

Nov. 9, 2026

From Writing Code to Running Agents: WeAreDevelopers Unveils the Program for Its First Conference in India

Indeterminate GlobeNewswire

Nov. 9, 2026

Solomon Global Offers Exclusive Signed Una and the Lion 2027 Gold Bullion Coins

Indeterminate GlobeNewswire

Nov. 9, 2026

CloudTalk launches a new AI Sales Dialer for even more live conversations: Customers report going from 15 to 100+ calls per agent per day

Indeterminate GlobeNewswire

Nov. 9, 2026

Boehringer Ingelheim's survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase III SYNCHRONIZE-CVOT trial alongside significant cardiometabolic benefits

Indeterminate GlobeNewswire

Nov. 9, 2026

Zealand Pharma announces Boehringer Ingelheim’s survodutide is the first glucagon/GLP-1 dual agonist to demonstrate a favorable cardiovascular safety profile in global Phase 3 SYNCHRONIZE-CVOT trial with significant cardiometabolic benefits

Indeterminate GlobeNewswire

Nov. 9, 2026

IDG Capital’s Consumer Investing Centers onThreeThemes: Brands, Transactions and Channels

Indeterminate EIN Presswire

Nov. 9, 2026

Oncovita Granted Orphan Drug Designation For MVdeltaC in Mesothelioma by the European Commission

Indeterminate GlobeNewswire

Nov. 9, 2026

SolidUltra secures €3 million to address AI data centers’ 800VDC power challenge

Indeterminate GlobeNewswire

Nov. 9, 2026

Pelareorep Induces Coordinated Antiviral Immune Responses and Enhanced Antitumor Immunity in Multiple Myeloma Patients

Indeterminate GlobeNewswire

Nov. 9, 2026

Performance Shipping Inc. Announces $4.0 Million Share Buyback Plan

Indeterminate GlobeNewswire

Nov. 9, 2026

CRISPR Therapeutics Presents Phase 1b Data for CTX310® Demonstrating Reductions in ANGPTL3 and Triglycerides in Patients with Severe Hypertriglyceridemia at the American Heart Association (AHA) Scientific Sessions 2026

Indeterminate GlobeNewswire

Nov. 9, 2026

NorthSea Therapeutics Announces Positive Phase 2 Topline Data in First-ever Randomized Placebo-controlled Study of an Oral Therapy in Intestinal Failure-Associated Liver Disease

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia Expands Fermentation Capacity in León, Spain

Indeterminate GlobeNewswire

Nov. 9, 2026

Q.ANT and IONOS Launch Photonic Computing Pilot

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia baut Fermentationskapazitäten am Standort León in Spanien aus

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia amplía su capacidad de fermentación en León, España

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia augmente sa capacité de fermentation à León, en Espagne

Indeterminate GlobeNewswire

Nov. 9, 2026

קוריה מרחיבה את כושר התסיסה שלה בלאון, ספרד

Indeterminate GlobeNewswire

Nov. 9, 2026

Curia Memperluas Kapasitas Fermentasi di León, Spanyol

Indeterminate GlobeNewswire

Nov. 9, 2026

キュリア、スペイン・レオンで発酵能力を拡大

Indeterminate GlobeNewswire